Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

ONCOLife

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

ONCOLife

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

ONCOLife

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

ONCOLife

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

Clinical Trials

ESMO 2024: BRAFTOVI and MEKTOVI Extend Survival in Rare Mutant Lung Cancer

Clinical Trials

ESMO 2024: Novartis's Kisqali Reduces Breast Cancer Recurrence Risk by 28.5%

ONCOLife

Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment

ONCOLife

Elevating Safety and Efficacy in Brain Tumor Treatment with the NB3 Laser Probe

ONCOLife

The Impact of Comprehensive Genomic Profiling on Personalized Cancer Care

Featured Articles

FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

21 October 2024

The FDA has approved Thermo Fisher’s Oncomine Dx Target Test, a next-generation sequencing based companion diagnostic, to identify patients eligible for Servier's VORANIGO® (vorasidenib)....

Trending Articles

Mixed-Reality System, HipInsight, Receives FDA Approval for Hip Surgery

Merck Ends KeyVibe-008 Trial Over Safety Concerns: A Setback in Lung Cancer

ONCOLife

9 August 2024

Healthy Planet: How The Pharmaceutical Industry Can Reduce Its Emissions

Opinion

9 August 2024

The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan

Pharma

9 August 2024

Iptacopan, the First CI, Wins FDA Accelerated Approval for IgA Nephropathy

FDA & EMA

8 August 2024

FDA Approves Vorasidenib as First Targeted Therapy for G2 IDH-Mutant Glioma

Novel CAR T Cell Therapy Targets Brain Cancer's Hidden Pathways, Doubling Survival

ONCOLife

6 August 2024

Novel Immunotherapy IMNN-001 Shows Extended Survival Rates for Ovarian Cancer

ONCOLife

3 August 2024

FDA Approves Expanded Use of Dostarlimab for Treatment of Endometrial Cancers

FDA & EMA

2 August 2024

Novel Cell Therapy Tecelra Receives FDA Accelerated Approval for Synovial Sarcoma

ONCOLife

2 August 2024

Transforming Tumor Analysis: LM AI Tool Enhances Lung Cancer Diagnostic Workflows

FDA Approves Expanded Use of Xembify for Immunodeficiency Treatment

FDA & EMA

29 July 2024

FDA Approves Johnson's Daratumumab Plus VRd for Newly Diagnosed Multiple Myeloma

FDA & EMA

30 July 2024

Anixa's CAR-T Therapy for Ovarian Cancer Earns FDA IND Approval

FDA & EMA

25 July 2024

FDA Approves First Blood Test for Early Detection and Screening of Colorectal Cancer

ONCOLife

31 July 2024